Organigram Holdings | OGI - 营业利润



金融业
股票价格
CAD 1.28
资产
CAD 820.26M
现金及等价物
CAD 10.85M
销售成本
CAD 64.36M
流动资产
CAD 280.09M
流动负债
CAD 107.28M
债务
CAD 31.45M
EBIT
CAD 5.33M
EBITDA
CAD 15.45M
员工
1.14K
EPS每股收益
CAD 0.77
股本和储备
CAD 485.46M
销售毛利
CAD 41.42M
债务利息支出
CAD 179K
贷款资金
CAD 17.61M
市值
CAD 123.75M
净收入
CAD 105.54M
营业费用
CAD 100.45M
营业利润
CAD 5.33M
普通股股本
CAD 140.98M
PE价格收益
15.55
税前利润
CAD 103.95M
销售收入
CAD 105.78M
销售和管理费用
CAD 26.51M
股票
CAD 165.06M
贸易债权人
CAD 99.93M
应收帐款人
CAD 88.61M


营业利润 更改 日
Acasti Pharma USD -2.53M 560K 2025-09
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -952K 60K 2026-06
Aurora Cannabis CAD -8.73M 1.3M 2026-06
Avita Medical AUD -6.86M 3.55M 2026-06
Canopy Growth CAD -17.58M 9.9M 2026-06
Cronos Group USD 7.6M 9.06M 2026-06
Dianthus Therapeutics USD -61.48M 14.95M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
IQVIA Holdings USD 608M 1.99B 2026-09
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Moderna USD -815M 573M 2026-06
Organigram Holdings CAD 5.33M 15.12M 2026-06
Organon & Co USD 377M 54M 2026-09
Revvity USD 124.63M 1.51M 2026-09
Tectonic Therapeutic USD -24.22M 3.08M 2026-06
Tilray USD -20.01M 9.34M 2025-09
Viatris USD 255.5M 181.8M 2026-09
Xeris Pharmaceuticals USD 5.17M 2.74M 2026-06